$MODV
ModivCare Inc Stock $modv

$modv Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000122075423000024 Filed on May 04, 2023

Income Statement

Concept	2023 Q2	2023 Q1
Revenue	$699.1M	$662.3M
YoY Change	11.28%	15.29%
Cost Of Revenue	$589.3M	$550.3M
YoY Change	16.86%	19.8%
Gross Profit	$109.9M	$112.0M
YoY Change	-11.4%	-2.71%
Gross Profit Margin	15.71%	16.92%
Selling, General & Admin	$79.24M	$79.71M
YoY Change	-0.22%	3.78%
% of Gross Profit	72.13%	71.15%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$25.91M	$5.792M
YoY Change	4.65%	29.98%
% of Gross Profit	23.59%	5.17%
Operating Expenses	$105.1M	$655.7M
YoY Change	-82.72%	17.07%
Operating Profit	$4.703M	$8.098M
YoY Change	-79.68%	-45.56%
Interest Expense	-$16.97M	-$15.96M
YoY Change	9.66%	3.62%
% of Operating Profit	-360.77%	-197.06%
Other Income/Expense, Net
YoY Change
Pretax Income	-$192.7M	-$7.860M
YoY Change	-2611.47%	1394.3%
Income Tax	-$830.0K	-$1.873M
% Of Pretax Income
Net Earnings	-$190.9M	-$3.962M
YoY Change	-5837.5%	-1345.91%
Net Earnings / Revenue	-27.31%	-0.6%
Basic Earnings Per Share	-$13.47	-$0.28
Diluted Earnings Per Share	-$13.47	-$0.28
COMMON SHARES
Basic Shares Outstanding	14.17M shares	14.15M shares
Diluted Shares Outstanding	14.17M shares	14.16M shares

Balance Sheet

Concept	2023 Q2	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$6.898M	$12.85M
YoY Change	-92.16%	-93.38%
Cash & Equivalents	$6.898M	$12.85M
Short-Term Investments
Other Short-Term Assets	$38.53M	$34.98M
YoY Change	44.0%	5.43%
Inventory	$1.449M	$1.416M
Prepaid Expenses
Receivables	$343.8M	$296.7M
Other Receivables	$2.295M	$2.246M
Total Short-Term Assets	$392.9M	$348.2M
YoY Change	-0.72%	-31.59%
LONG-TERM ASSETS
Property, Plant & Equipment	$118.2M	$116.6M
YoY Change	88.44%	102.1%
Goodwill	$785.6M	$968.7M
YoY Change	-18.89%	4.74%
Intangibles	$38.83M	$43.25M
YoY Change	-30.82%	-28.21%
Long-Term Investments	$45.11M	$43.70M
YoY Change	-43.86%	-47.56%
Other Assets	$42.89M	$44.46M
YoY Change	36.74%	76.25%
Total Long-Term Assets	$1.392B	$1.593B
YoY Change	-16.33%	-0.66%
TOTAL ASSETS
Total Short-Term Assets	$392.9M	$348.2M
Total Long-Term Assets	$1.392B	$1.593B
Total Assets	$1.785B	$1.942B
YoY Change	-13.33%	-8.11%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$56.05M	$54.99M
YoY Change	427.65%	44.51%
Accrued Expenses	$241.6M	$133.0M
YoY Change	95.62%	-3.69%
Deferred Revenue	$2.355M	$2.155M
YoY Change	-1.09%	-61.84%
Short-Term Debt	$126.5M	$15.00M
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$533.2M	$494.2M
YoY Change	-3.65%	-19.38%
LONG-TERM LIABILITIES
Long-Term Debt	$981.5M	$980.4M
YoY Change	0.44%	0.43%
Other Long-Term Liabilities	$61.85M	$29.36M
YoY Change	102.0%	24.4%
Total Long-Term Liabilities	$1.043B	$1.010B
YoY Change	3307.82%	4179.13%
TOTAL LIABILITIES
Total Short-Term Liabilities	$533.2M	$494.2M
Total Long-Term Liabilities	$1.043B	$1.010B
Total Liabilities	$1.624B	$1.590B
YoY Change	-3.22%	-8.43%
SHAREHOLDERS EQUITY
Retained Earnings	-$14.88M	$176.1M
YoY Change	-106.91%	-17.01%
Common Stock	$446.7M	$445.4M
YoY Change	2.43%	2.71%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$161.4M	$351.1M
YoY Change
Total Liabilities & Shareholders Equity	$1.785B	$1.942B
YoY Change	-13.33%	-8.11%

Cashflow Statement

Concept	2023 Q2	2023 Q1
OPERATING ACTIVITIES
Net Income	-$190.9M	-$3.962M
YoY Change	-5837.5%	-1345.91%
Depreciation, Depletion And Amortization	$25.91M	$5.792M
YoY Change	4.65%	29.98%
Cash From Operating Activities	-$108.2M	-$2.655M
YoY Change	505.79%	-103.84%
INVESTING ACTIVITIES
Capital Expenditures	$8.945M	$13.32M
YoY Change	-222.28%	55.17%
Acquisitions
YoY Change
Other Investing Activities	$0.00
YoY Change	-100.0%
Cash From Investing Activities	-$8.945M	-$13.32M
YoY Change	-89.62%	55.17%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	111.3M	$14.38M
YoY Change	-4640.82%	2440.64%
NET CHANGE
Cash From Operating Activities	-108.2M	-$2.655M
Cash From Investing Activities	-8.945M	-$13.32M
Cash From Financing Activities	111.3M	$14.38M
Net Change In Cash	-5.914M	-$1.595M
YoY Change	-94.45%	-102.61%
FREE CASH FLOW
Cash From Operating Activities	-$108.2M	-$2.655M
Capital Expenditures	$8.945M	$13.32M
Free Cash Flow	-$117.2M	-$15.98M
YoY Change	1010.66%	-126.41%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001220754
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-34221
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	ModivCare Inc.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	86-0845127
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	6900 E Layton Avenue
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	12th Floor
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Denver
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CO
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	80237
CY2023Q1	dei	City Area Code CityAreaCode	303
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	728-7030
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock, $0.001 par value per share
CY2023Q1	dei	Trading Symbol TradingSymbol	MODV
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	14166601	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12848000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14451000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	2205000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	2078000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	296745000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	294341000	usd
CY2023Q1	us-gaap	Other Receivables OtherReceivables	2246000	usd
CY2022Q4	us-gaap	Other Receivables OtherReceivables	2506000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	35860000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	34332000	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	532000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	524000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	348231000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	346154000	usd
CY2023Q1	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	76252000	usd
CY2022Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	69138000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	968654000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	968654000	usd
CY2023Q1	modv	Intangible Assets Payor Network Net IntangibleAssetsPayorNetworkNet	376672000	usd
CY2022Q4	modv	Intangible Assets Payor Network Net IntangibleAssetsPayorNetworkNet	391980000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	43250000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	47429000	usd
CY2023Q1	us-gaap	Equity Method Investments EquityMethodInvestments	43698000	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	41303000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	40311000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	39405000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	44461000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	40209000	usd
CY2023Q1	us-gaap	Assets Assets	1941529000	usd
CY2022Q4	us-gaap	Assets Assets	1944272000	usd
CY2023Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	15000000	usd
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	0	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	54987000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	54959000	usd
CY2023Q1	modv	Accrued Contract Payables AccruedContractPayables	187620000	usd
CY2022Q4	modv	Accrued Contract Payables AccruedContractPayables	194287000	usd
CY2023Q1	modv	Accrued Transportation Costs AccruedTransportationCosts	93726000	usd
CY2022Q4	modv	Accrued Transportation Costs AccruedTransportationCosts	96851000	usd
CY2023Q1	modv	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	132978000	usd
CY2022Q4	modv	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	135860000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	9852000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	9640000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	494163000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	491597000	usd
CY2023Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	19567000	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	20639000	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	980433000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	979361000	usd
CY2023Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	53612000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	57236000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	32867000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	32088000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	29356000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	29434000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	1590431000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	1589716000	usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	40000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	40000000	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	354556000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1941529000	usd
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	19755832	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	19755832	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	19729923	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	19729923	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	20000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	20000	usd
CY2023Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	445379000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	444255000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	176061000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	180023000	usd
CY2023Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	5579529	shares
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	5573529	shares
CY2023Q1	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	270362000	usd
CY2022Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	269742000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	351098000	usd
CY2022Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-15400000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1944272000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	662306000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	574475000	usd
CY2023Q1	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	1464000	usd
CY2022Q1	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	468000	usd
CY2023Q1	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	550266000	usd
CY2022Q1	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	459315000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	79713000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	76808000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	25693000	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	23946000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	655672000	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	560069000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	8098000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	14874000	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-15958000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7860000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-526000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1873000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-361000	usd
CY2023Q1	modv	Equity Method Investment Income Loss Net Of Tax EquityMethodInvestmentIncomeLossNetOfTax	2025000	usd
CY2022Q1	modv	Equity Method Investment Income Loss Net Of Tax EquityMethodInvestmentIncomeLossNetOfTax	483000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-3962000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	318000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.28
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.28
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14163511	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14023585	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14163511	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14123825	shares
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-3962000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	318000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	5792000	usd
CY2022Q1	us-gaap	Depreciation Depreciation	4456000	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	19901000	usd
CY2022Q1	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	19490000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1124000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2049000	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-3624000	usd
CY2022Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-6587000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1278000	usd
CY2022Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1008000	usd
CY2023Q1	modv	Increase Decrease In Other Assets IncreaseDecreaseInOtherAssets	4253000	usd
CY2022Q1	modv	Increase Decrease In Other Assets IncreaseDecreaseInOtherAssets	3004000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	2810000	usd
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	671000	usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	3547000	usd
CY2022Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	2884000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1730000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	42646000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1734000	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-7298000	usd
CY2023Q1	modv	Increase Decrease In Contract Payables IncreaseDecreaseInContractPayables	-6667000	usd
CY2022Q1	modv	Increase Decrease In Contract Payables IncreaseDecreaseInContractPayables	34433000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-2854000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	49289000	usd
CY2023Q1	modv	Increase Decrease In Accrued Transportation Costs IncreaseDecreaseInAccruedTransportationCosts	-3125000	usd
CY2022Q1	modv	Increase Decrease In Accrued Transportation Costs IncreaseDecreaseInAccruedTransportationCosts	3895000	usd
CY2023Q1	modv	Increase Decrease In Other Long Term Liabilities IncreaseDecreaseInOtherLongTermLiabilities	-3538000	usd
CY2022Q1	modv	Increase Decrease In Other Long Term Liabilities IncreaseDecreaseInOtherLongTermLiabilities	-727000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2655000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	71485000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	13320000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	8584000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-13320000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-8584000	usd
CY2023Q1	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	15000000	usd
CY2022Q1	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	0	usd
CY2023Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
CY2022Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	2415000	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
CY2022Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1138000	usd
CY2023Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	620000	usd
CY2022Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	572000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	14380000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1849000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1595000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	61052000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14975000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	133422000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13380000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	194474000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	1200000	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	551000	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	429000	usd
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	892000	usd
CY2023Q1	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	4453000	usd
CY2022Q1	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	1314000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	354556000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-3962000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1039000	usd
CY2023Q1	modv	Stock Issued During Period Value Performance Restricted Stock Award Gross StockIssuedDuringPeriodValuePerformanceRestrictedStockAwardGross	-620000	usd
CY2023Q1	modv	Stock Issued During Period Value Shares Issued For Bonus Settlement And Director Stipends Gross StockIssuedDuringPeriodValueSharesIssuedForBonusSettlementAndDirectorStipendsGross	85000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	351098000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	373267000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	318000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1963000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1138000	usd
CY2022Q1	modv	Stock Issued During Period Value Performance Restricted Stock Award Gross StockIssuedDuringPeriodValuePerformanceRestrictedStockAwardGross	-572000	usd
CY2022Q1	modv	Stock Issued During Period Value Shares Issued For Bonus Settlement And Director Stipends Gross StockIssuedDuringPeriodValueSharesIssuedForBonusSettlementAndDirectorStipendsGross	86000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	376200000	usd
CY2023Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	Reclassifications: Certain prior year amounts have been reclassified to conform to current year presentation.
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, including disclosure of contingencies, at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></div>
CY2023Q1	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	500000	usd
CY2022Q1	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	200000	usd
CY2023Q1	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	1500000	usd
CY2022Q1	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	500000	usd
CY2023Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	4	segment
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	662306000	usd
CY2023Q1	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	1464000	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	550266000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	79713000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	25693000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	8098000	usd
CY2023Q1	modv	Equity Method Investment Gain Loss From Continuing Operations EquityMethodInvestmentGainLossFromContinuingOperations	2025000	usd
CY2023Q1	us-gaap	Equity Method Investments EquityMethodInvestments	43698000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	968654000	usd
CY2023Q1	us-gaap	Assets Assets	1941529000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	574475000	usd
CY2022Q1	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	468000	usd
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	459315000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	76808000	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	23946000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	14874000	usd
CY2022Q1	modv	Equity Method Investment Gain Loss From Continuing Operations EquityMethodInvestmentGainLossFromContinuingOperations	483000	usd
CY2022Q1	us-gaap	Equity Method Investments EquityMethodInvestments	83333000	usd
CY2022Q1	us-gaap	Goodwill Goodwill	924787000	usd
CY2022Q1	us-gaap	Assets Assets	2112984000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	662306000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	574475000	usd
CY2023Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	200926000	usd
CY2022Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	225288000	usd
CY2023Q1	modv	Contract With Customer Asset Receivable Reconciliation ContractWithCustomerAssetReceivableReconciliation	98024000	usd
CY2022Q4	modv	Contract With Customer Asset Receivable Reconciliation ContractWithCustomerAssetReceivableReconciliation	71131000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	2205000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	2078000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	296745000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	294341000	usd
CY2022Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	187620000	usd
CY2022	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	194287000	usd
CY2023Q1	us-gaap	Receivables Long Term Contracts Or Programs ReceivablesLongTermContractsOrPrograms	4324000	usd
CY2022Q4	us-gaap	Receivables Long Term Contracts Or Programs ReceivablesLongTermContractsOrPrograms	427000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2155000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2202000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	194287000	usd
CY2023Q1	modv	Contract With Customer Liability Additional Amounts Recorded ContractWithCustomerLiabilityAdditionalAmountsRecorded	24926000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Modification Of Contract ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract	31593000	usd
CY2023Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	187620000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	71558000	usd
CY2023Q1	modv	Contract With Customer Asset Additional Amounts Recorded ContractWithCustomerAssetAdditionalAmountsRecorded	36712000	usd
CY2023Q1	us-gaap	Contract With Customer Asset Cumulative Catch Up Adjustment To Revenue Modification Of Contract ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueModificationOfContract	5922000	usd
CY2023Q1	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	102348000	usd
CY2023Q1	us-gaap	Prepaid Taxes PrepaidTaxes	5297000	usd
CY2022Q4	us-gaap	Prepaid Taxes PrepaidTaxes	7186000	usd
CY2023Q1	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	5231000	usd
CY2022Q4	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	5817000	usd
CY2023Q1	us-gaap	Prepaid Insurance PrepaidInsurance	3513000	usd
CY2022Q4	us-gaap	Prepaid Insurance PrepaidInsurance	6334000	usd
CY2023Q1	us-gaap	Deferred Finance Costs Current Gross DeferredFinanceCostsCurrentGross	2919000	usd
CY2022Q4	us-gaap	Deferred Finance Costs Current Gross DeferredFinanceCostsCurrentGross	3061000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	1416000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	2041000	usd
CY2023Q1	us-gaap	Prepaid Rent PrepaidRent	1290000	usd
CY2022Q4	us-gaap	Prepaid Rent PrepaidRent	278000	usd
CY2023Q1	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	16194000	usd
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	9615000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	35860000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	34332000	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	49466000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	47947000	usd
CY2023Q1	us-gaap	Interest Payable Current InterestPayableCurrent	24177000	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	10643000	usd
CY2023Q1	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	19577000	usd
CY2022Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	17836000	usd
CY2023Q1	modv	Accrued Operating Expense Current AccruedOperatingExpenseCurrent	11229000	usd
CY2022Q4	modv	Accrued Operating Expense Current AccruedOperatingExpenseCurrent	18432000	usd
CY2023Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	9143000	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	15574000	usd
CY2023Q1	modv	Accrued Union Pension Obligation Current AccruedUnionPensionObligationCurrent	3548000	usd
CY2022Q4	modv	Accrued Union Pension Obligation Current AccruedUnionPensionObligationCurrent	3665000	usd
CY2023Q1	modv	Accrued Government Grants Current AccruedGovernmentGrantsCurrent	3464000	usd
CY2022Q4	modv	Accrued Government Grants Current AccruedGovernmentGrantsCurrent	7367000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2155000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2202000	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	10219000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	12194000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	132978000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	135860000	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P3Y
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P3Y
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-3962000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	318000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14163511	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14023585	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14163511	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14123825	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.28
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.28
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.238
CY2022Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.686

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
modv-20230331_lab.xml	Edgar Link	unprocessable
0001220754-23-000024-index-headers.html	Edgar Link	pending
0001220754-23-000024-index.html	Edgar Link	pending
0001220754-23-000024.txt	Edgar Link	pending
0001220754-23-000024-xbrl.zip	Edgar Link	pending
ex311-modvq13312023ex311.htm	Edgar Link	pending
ex312-modvq13312023ex312.htm	Edgar Link	pending
ex321-modvq13312023ex321.htm	Edgar Link	pending
ex322-modvq13312023ex322.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
formofperformancerestricte.htm	Edgar Link	pending
gwraymodivcareseparationan.htm	Edgar Link	pending
image_0.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
modv-20230331.htm	Edgar Link	pending
modv-20230331.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
modv-20230331_def.xml	Edgar Link	unprocessable
modv-20230331_cal.xml	Edgar Link	unprocessable
modv-20230331_pre.xml	Edgar Link	unprocessable
modv-20230331_htm.xml	Edgar Link	completed
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MODV
ModivCare Inc Stock $modv

2023 Q2 Form 10-Q Financial Statement

#000122075423000024 Filed on May 04, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MODV ModivCare Inc Stock $modv

2023 Q2 Form 10-Q Financial Statement

#000122075423000024 Filed on May 04, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MODV
ModivCare Inc Stock $modv